双PB2/JAK2抑制剂的合理设计可以实现平衡的抗病毒和宿主导的免疫调节作用
Yujian Yang1, Binhao Rong2, Huanyu Shi1
1Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Department of Chemistry, Shenzhen Grubbs Institute and Medi-X Pingshan, Southern University of Science and Technology, Shenzhen, 518000, China.
European journal of medicinal chemistry
|February 15, 2026
概括
这项研究引入了一种新的双重目标策略来治疗流感,抑制病毒和宿主炎症. 化合物4B显示出强大的抗病毒和抗炎作用,提供了一个有前途的治疗方法.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 流感病毒感染会引发过度的免疫反应,导致细胞因子风暴,严重的炎症,肺炎和心肌炎.
- 目前的治疗方法可能无法完全解决病毒复制和有害宿主免疫反应.
研究的目的:
- 设计和发现新型双抑制剂,同时向病毒PB2蛋白和宿主JAK2激酶.
- 评估这些抑制剂对抗病毒感染和调节免疫反应的有效性.
主要方法:
- 合理的药物设计和结构导向优化被用来识别强效抑制剂.
- 合成了4B化合物,其抗H1N1活性和JAK2抑制作用在体外进行了评估.
- 化合物4B的药理动力学特性在小鼠中进行了评估.
- 分析了化合物4B对病毒蛋白表达和促炎性细胞因子mRNA水平的影响.
主要成果:
- 化合物4B表现出强大的抗H1N1活性 (EC50 = 15nM) 和JAK2抑制 (IC50 = 49nM).
- 化合物4B在小鼠中表现出极好的口服生物利用率 (99.4%),并显著降低了病毒NP和PB2蛋白表达.
- 在相关模型中,用4B化合物治疗抑制了关键的促炎细胞因子 (IL-6,TNF-α,IFN-β) 的mRNA表达.
结论:
- 开发的双重目标战略有效地抑制了流感病毒的复制,并减轻了过度的宿主炎症反应.
- 化合物4B代表了一种有前途的流感治疗候选药物,它可以解决病毒载量和细胞因子风暴.
- 针对病毒蛋白和宿主激酶的双抑制为开发新型抗流感药物提供了可行的策略.
相关概念视频
01:25Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
01:29Immune Response Against Viral Pathogens
2.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:27Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
271
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
271